2018 U.S.-Booked Air Volume: $47.8 million
2018 Global Air Volume: $84.2 million
2018 U.S. T&E: $162 million
2018 Global T&E: $258.8 million
Primary Air Suppliers: Delta, United, American
Primary Hotel Suppliers: Marriott, Hilton, intercontinental
Primary Car Rental Supplier: Hertz
Primary Global Online Booking Tool: Concur
Primary U.S. Payment Supplier: Citi
Card Program: individual bill, central pay
Primary Global Expense Supplier: Concur
Primary Global Travel Risk Management Supplier: Anvil
Consolidated Global TMC: Amex GBT
Medical device manufacturer Boston Scientific earned $9.8 billion in revenue in 2018 and is spending less on corporate travel thanks to new contracts that leverage competition in legacy markets. U.S.-booked air spend fell 5.5 percent in 2018 from 2017's $50.6 million and is projected to jump to $64.2 million this year. Thirty-eight percent of 2018 U.S.-booked volume was for crossborder flights. The company has a single, global travel policy. Seventy-nine percent of U.S.-booked air tickets went through approved online tools, and 59 percent of those required no agent assistance. Boston Scientific acquired several companies in 2018, and the workforce has grown to more than 35,000. The travel program emphasizes data mining and understanding traveler behavior to optimize the program.